• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SMART COIL; HCG, KRD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SMART COIL; HCG, KRD Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Thrombosis (2100); Embolism/Embolus (4438)
Event Date 08/01/2015
Event Type  Death  
Manufacturer Narrative
The product was not returned for evaluation.From the information provided, there is no indication that there was any device malfunction, nonconformance, or misuse that contributed to the reported event.Potential adverse events in the labeling with the penumbra smart coil system include, but are not limited to, thromboembolic episodes, neurological deficits including stroke, peripheral thromboembolic events, including death.The product lot number was not provided, therefore, the manufacturing records could not be reviewed.
 
Event Description
During its post-market surveillance activities on 17-dec-2020, penumbra inc.Became aware of a journal article titled, "long-term follow-up results of the smart coil in the endovascular treatment of intracranial aneurysms." (mcavoy et al.2020).This article reports a single center prospective analysis of one hundred and five patients undergoing a total of one hundred and six procedures utilizing at least one penumbra smart coil (smart coil) between august 2015 and july 2018.During one procedure, an intraoperative thromboembolic complication occurred in which an occlusion of the m2 and m3 segments of the middle cerebral artery (mca) caused a parenchymal defect.Following the administration of 4000 units of intravenous heparin, the degree of occlusion improved.However, another parenchymal defect caused by an occlusion in the right a2 segment of the anterior cerebral artery (aca) was discovered in the post-operative setting.Post-procedure, the patient began to decline neurologically and expired two days post-procedure.There was no reported procedural complication with a smart coil.It should be noted that it is unclear if a smart coil was being used when the thromboembolic complication occurred and the cause of death was not specified.It was not possible to ascertain specific device or patient information from the article, or to match the events reported with previously reported complaints.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SMART COIL
Type of Device
HCG, KRD
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key11178094
MDR Text Key227048602
Report Number3005168196-2021-00096
Device Sequence Number1
Product Code HCG
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K160832
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 01/01/2005,12/17/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Initial Date Manufacturer Received 12/17/2020
Initial Date FDA Received01/15/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
-
-